Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(42.9%)

Phase 3

2(28.6%)

Phase 4

1(14.3%)

Phase 2

1(14.3%)

7Total

N/A(3)

Phase 3(2)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06114810Phase 4Unknown

Immunogenicity of Novel Oral Poliovirus Vaccine Type 2 (nOPV2), bOPV and IPV

Role: collaborator

NCT00434408Phase 3Completed

Impact of Umbilical Cord Cleansing With 4.0% Chlorhexidine on Neonatal Mortality

Role: collaborator

NCT04559711Not ApplicableUnknown

cRCT to Improve Maternal Nutrition Service Delivery During ANC

Role: collaborator

NCT03032276Not ApplicableUnknown

Safe Motherhood Promotion and Newborn Survival

Role: collaborator

NCT02727855Completed

Cholera Vaccine Investment Strategy in Bangladesh

Role: collaborator

NCT02027207Phase 3Completed

Single Dose Oral Cholera Vaccine Study in Dhaka, Bangladesh

Role: collaborator

NCT01811771Not ApplicableCompleted

Oral Cholera Vaccine Delivery in Rural Bangladesh

Role: collaborator

NCT01042951Phase 2Completed

To Determine the Safety and Immunogenicity of an Oral Whole Cell ShanChol Cholera Vaccine in Bangladesh

Role: collaborator

All 8 trials loaded